000 01334 a2200337 4500
005 20250517115015.0
264 0 _c20170228
008 201702s 0 0 eng d
022 _a2211-0356
024 7 _a10.1016/j.msard.2016.07.015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrebenciucova, Elena
245 0 0 _aImmunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
_h[electronic resource]
260 _bMultiple sclerosis and related disorders
_cSep 2016
300 _a158-62 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Review
650 0 4 _aCryptococcosis
_xetiology
650 0 4 _aFemale
650 0 4 _aFingolimod Hydrochloride
_xadverse effects
650 0 4 _aHumans
650 0 4 _aImmunosenescence
_xdrug effects
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Sclerosis, Relapsing-Remitting
_xcomplications
650 0 4 _aT-Lymphocyte Subsets
_ximmunology
700 1 _aReder, Anthony T
700 1 _aBernard, Jacqueline T
773 0 _tMultiple sclerosis and related disorders
_gvol. 9
_gp. 158-62
856 4 0 _uhttps://doi.org/10.1016/j.msard.2016.07.015
_zAvailable from publisher's website
999 _c26432737
_d26432737